Search Results

You are looking at 11 - 20 of 96 items for :

  • "skin cancer" x
Clear All
Full access

Basal cell and squamous cell skin cancers are the most common human cancers. They were estimated to have an incidence of more than one million cases in the United States in 2003. Although rarely metastatic, basal cell and squamous cell cancers can produce significant local destruction and disfigurement and may involve extensive areas of soft tissue, cartilage, and bone. The estimated annual cost of treating these two diseases in the United States exceeds $500 million.

For the most recent version of the guidelines, please visit NCCN.org

Full access

Stanley J. Miller, Murad Alam, James S. Andersen, Daniel Berg, Christopher K. Bichakjian, Glen M. Bowen, Richard T. Cheney, L. Frank Glass, Roy C. Grekin, Alan L. Ho, Anne Kessinger, Nanette Liegeois, Daniel D. Lydiatt, Jeff Michalski, William H. Morrison, Kishwer S. Nehal, Kelly C. Nelson, Paul Nghiem, Thomas Olencki, Clifford S. Perlis, Ashok R. Shaha, Malika Tuli, Marshall M. Urist, Linda C. Wang and John A. Zic

Overview The NCCN Non-Melanoma Skin Cancer Panel has developed these guidelines outlining the treatment of dermatofibrosarcoma protuberans (DFSP) to supplement their other guidelines (NCCN Clinical Practice Guidelines in Oncology [NCCN

Full access

Daniel G. Coit, Robert Andtbacka, Christopher K. Bichakjian, Raza A. Dilawari, Dominick DiMaio, Valerie Guild, Allan C. Halpern, F. Stephen Hodi, Mohammed Kashani-Sabet, Julie R. Lange, Anne Lind, Lainie Martin, Mary C. Martini, Scott K. Pruitt, Merrick I. Ross, Stephen F. Sener, Susan M. Swetter, Kenneth K. Tanabe, John A. Thompson, Vijay Trisal, Marshall M. Urist, Jeffrey Weber and Michael K. Wong

: 481 – 492 . 6 Jensen EH Margolin KA Sondak VK . Melanoma and other skin cancers . In: Pazdur R Coia L Hoskins WJ Wagman LD , eds. Cancer Management: A Multidisciplinary Approach , 9th edition . New York : CMP Media ; 2005 : 531 – 562

Full access

Daniel G. Coit, Robert Andtbacka, Christopher J. Anker, Christopher K. Bichakjian, William E. Carson III, Adil Daud, Raza A. Dilawari, Dominick DiMaio, Valerie Guild, Allan C. Halpern, F. Stephen Hodi Jr., Mark C. Kelley, Nikhil I. Khushalani, Ragini R. Kudchadkar, Julie R. Lange, Anne Lind, Mary C. Martini, Anthony J. Olszanski, Scott K. Pruitt, Merrick I. Ross, Susan M. Swetter, Kenneth K. Tanabe, John A. Thompson, Vijay Trisal and Marshall M. Urist

patients. Education on skin cancer prevention, including sun protection measures, should be promoted for patients with melanoma and their families. 142 Increasing evidence shows that regular sunscreen use may diminish the incidence of subsequent melanoma

Full access

Brent E. Pennington and Thomas Stasko

epidemiology of skin cancer . Br J Dermatol 2002 ; 146 : 1 – 6 . 3 Winkelhorst JT Brokelman WJ Tiggeler RG Wobbes T . Incidence and clinical course of de-novo malignancies in renal allograft recipients . Eur J Surg Oncol 2001 ; 27 : 409 – 413

Full access

Christopher K. Bichakjian, Thomas Olencki, Murad Alam, James S. Andersen, Daniel Berg, Glen M. Bowen, Richard T. Cheney, Gregory A. Daniels, L. Frank Glass, Roy C. Grekin, Kenneth Grossman, Alan L. Ho, Karl D. Lewis, Daniel D. Lydiatt, William H. Morrison, Kishwer S. Nehal, Kelly C. Nelson, Paul Nghiem, Clifford S. Perlis, Ashok R. Shaha, Wade L. Thorstad, Malika Tuli, Marshall M. Urist, Timothy S. Wang, Andrew E. Werchniak, Sandra L. Wong, John A. Zic, Karin G. Hoffmann, Nicole R. McMillian and Maria Ho

cell carcinoma (MCC) is a rare, aggressive cutaneous tumor that combines the local recurrence rates of infiltrative nonmelanoma skin cancer along with the regional and distant metastatic rates of thick melanoma. 1 Several large reviews document the

Full access

Ata S. Moshiri and Paul Nghiem

fact that MCC is histologically unique and far more aggressive than typical nonmelanoma skin cancers led not only to its own staging system but also to its independent codes under the International Classification of Diseases and Related Health Problems

Full access

Stanley J. Miller, Murad Alam, James Andersen, Daniel Berg, Christopher K. Bichakjian, Glen Bowen, Richard T. Cheney, L. Frank Glass, Roy C. Grekin, Dennis E. Hallahan, Anne Kessinger, Nancy Y. Lee, Nanette Liegeois, Daniel D. Lydiatt, Jeff Michalski, William H. Morrison, Kishwer S. Nehal, Kelly C. Nelson, Paul Nghiem, Thomas Olencki, Allan R. Oseroff, Clifford S. Perlis, E. William Rosenberg, Ashok R. Shaha, Marshall M. Urist and Linda C. Wang

, eds. Skin Cancer . Hamilton (Ontario) : BC Decker Inc. ; 2001 : 127 – 141 . 19 Allen PJ Bowne WB Jaques DP . Merkel cell carcinoma: prognosis and treatment of patients from a single institution . J Clin Oncol 2005 ; 23 : 2300 – 2309

Full access

Victoria T. Brown, Dana Drzayich Antol, Patrick N. Racsa, Melea A. Ward and Jarushka Naidoo

, corticosteroids, anti-TNFα). Results: 6,005 patients were identified; 39.1% were female, median (IQR) age was 72 years (67–77). The majority (64.7%) had thoracic cancers; 16.3% genitourinary cancers; and 12.8% skin cancers. The median number of anti-PD1/PD-L1

Full access

Merkel cell carcinoma (MCC) is a rare, aggressive cutaneous tumor that combines the local recurrence rates of infiltrative non-melanoma skin cancer with the regional and distant metastatic rates of thick melanoma. The mortality rate of MCC exceeds that of melanoma, and the 5-year disease-specific survival rate is 64%. These guidelines and most biomedical literature suggest that the workup of a patient with MCC should include chest radiograph and additional studies as clinically indicated. These guidelines, which the NCCN Non-Melanoma Skin Cancer Panel developed as a supplement to those for squamous cell and basal cell skin cancer, also outline treatment strategies.

For the most recent version of the guidelines, please visit NCCN.org